Literature DB >> 22307976

Delta-aminolevulinate-induced host-parasite porphyric disparity for selective photolysis of transgenic Leishmania in the phagolysosomes of mononuclear phagocytes: a potential novel platform for vaccine delivery.

Sujoy Dutta1, Celia Chang, Bala Krishna Kolli, Shigeru Sassa, Malik Yousef, Michael Showe, Louise Showe, Kwang-Poo Chang.   

Abstract

Leishmania double transfectants (DTs) expressing the 2nd and 3rd enzymes in the heme biosynthetic pathway were previously reported to show neogenesis of uroporphyrin I (URO) when induced with delta-aminolevulinate (ALA), the product of the 1st enzyme in the pathway. The ensuing accumulation of URO in DT promastigotes rendered them light excitable to produce reactive oxygen species (ROS), resulting in their cytolysis. Evidence is presented showing that the DTs retained wild-type infectivity to their host cells and that the intraphagolysosomal/parasitophorous vacuolar (PV) DTs remained ALA inducible for uroporphyrinogenesis/photolysis. Exposure of DT-infected cells to ALA was noted by fluorescence microscopy to result in host-parasite differential porphyrinogenesis: porphyrin fluorescence emerged first in the host cells and then in the intra-PV amastigotes. DT-infected and control cells differed qualitatively and quantitatively in their porphyrin species, consistent with the expected multi- and monoporphyrinogenic specificities of the host cells and the DTs, respectively. After ALA removal, the neogenic porphyrins were rapidly lost from the host cells but persisted as URO in the intra-PV DTs. These DTs were thus extremely light sensitive and were lysed selectively by illumination under nonstringent conditions in the relatively ROS-resistant phagolysosomes. Photolysis of the intra-PV DTs returned the distribution of major histocompatibility complex (MHC) class II molecules and the global gene expression profiles of host cells to their preinfection patterns and, when transfected with ovalbumin, released this antigen for copresentation with MHC class I molecules. These Leishmania mutants thus have considerable potential as a novel model of a universal vaccine carrier for photodynamic immunotherapy/immunoprophylaxis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22307976      PMCID: PMC3318301          DOI: 10.1128/EC.05202-11

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  38 in total

1.  Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line.

Authors:  P Ralph; I Nakoinz
Journal:  Nature       Date:  1975-10-02       Impact factor: 49.962

2.  Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1.

Authors:  R Snyderman; M C Pike; D G Fischer; H S Koren
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

3.  Genetic rescue of Leishmania deficiency in porphyrin biosynthesis creates mutants suitable for analysis of cellular events in uroporphyria and for photodynamic therapy.

Authors:  Jerome Franklin Sah; Hiroya Ito; Bala Krishna Kolli; Daniel A Peterson; Shigeru Sassa; Kwang-Poo Chang
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

4.  Heme requirement and acquisition by extracellular and intracellular stages of Leishmania mexicana amazonensis.

Authors:  C S Chang; K P Chang
Journal:  Mol Biochem Parasitol       Date:  1985-09       Impact factor: 1.759

5.  Isolation and sequencing of a cDNA clone encoding lysosomal membrane glycoprotein mouse LAMP-1. Sequence similarity to proteins bearing onco-differentiation antigens.

Authors:  J W Chen; Y Cha; K U Yuksel; R W Gracy; J T August
Journal:  J Biol Chem       Date:  1988-06-25       Impact factor: 5.157

6.  Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response.

Authors:  Jude E Uzonna; Gerald F Späth; Stephen M Beverley; Phillip Scott
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

Review 7.  The involvement of oxygen radicals in microbicidal mechanisms of leukocytes and macrophages.

Authors:  D Roos
Journal:  Klin Wochenschr       Date:  1991-12-15

Review 8.  Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?

Authors:  Diane McMahon-Pratt; James Alexander
Journal:  Immunol Rev       Date:  2004-10       Impact factor: 12.988

Review 9.  Cell biology of host-parasite membrane interactions in leishmaniasis.

Authors:  K P Chang; D Fong
Journal:  Ciba Found Symp       Date:  1983

Review 10.  The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis.

Authors:  Clive J Kelty; Nicola J Brown; Malcolm W R Reed; Roger Ackroyd
Journal:  Photochem Photobiol Sci       Date:  2002-03       Impact factor: 3.982

View more
  6 in total

1.  Aminophthalocyanine-Mediated Photodynamic Inactivation of Leishmania tropica.

Authors:  Ahmed Al-Qahtani; Saad Alkahtani; Bala Kolli; Pankaj Tripathi; Sujoy Dutta; Abdullah A Al-Kahtane; Xiong-Jie Jiang; Dennis K P Ng; Kwang Poo Chang
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 2.  New "light" for one-world approach toward safe and effective control of animal diseases and insect vectors from leishmaniac perspectives.

Authors:  Kwang Poo Chang; Bala K Kolli
Journal:  Parasit Vectors       Date:  2016-07-13       Impact factor: 3.876

3.  Vaccination for Disease Prevention and Control: the Necessity of Renewed Emphasis and New Approaches.

Authors:  Kwang Poo Chang
Journal:  J Immunol Immunotech       Date:  2014-07-09

4.  Novel phthalocyanines activated by dim light for mosquito larva- and cell-inactivation with inference for their potential as broad-spectrum photodynamic insecticides.

Authors:  Shin-Hong Shiao; Shih-Che Weng; Liqiang Luan; Maria da Graça H Vicente; Xiong-Jie Jiang; Dennis K P Ng; Bala Krishna Kolli; Kwang Poo Chang
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

Review 5.  Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?

Authors:  Kwang Poo Chang; Joseph M Reynolds; Ying Liu; Johnny J He
Journal:  Vaccines (Basel)       Date:  2022-02-07

6.  Photodynamic inactivation of Leishmania braziliensis doubly sensitized with uroporphyrin and diamino-phthalocyanine activates effector functions of macrophages in vitro.

Authors:  Rohit Sharma; Sayonara M Viana; Dennis K P Ng; Bala K Kolli; Kwang Poo Chang; Camila I de Oliveira
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.